Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-Week results from the JESMR study

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1585-1592

  Kameda, Hideto ^a,b   Kanbe, Katsuaki ^a,c   Sato, Eri ^a,d   Ueki, Yukitaka ^a,f   Saito, Kazuyoshi ^a,g   Nagaoka, Shouhei ^a,h   Hidaka, Toshihiko ^a,i   Atsumi, Tatsuya ^a,j   Tsukano, Michishi ^a,k   Kasama, Tsuyoshi ^a,e   Shiozawa, Shunichi ^a,l   Tanaka, Yoshiya ^a,g   Yamanaka, Hisashi ^a,d   Takeuchi, Tsutomu ^a,b  

^a Japan Biological Agent Integrated Consortium ^*  (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SASEBO CHUO HOSPITAL   (Japan)

^g UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^h Yokohama Minami Kyosai Hospital   (Japan)

ⁱ Zenjinkai Shimin No Mori Hospital   (Japan)

^j HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k Kumamoto Orthopaedic Hospital   (Japan)

^l KOBE UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Methotrexate; Rheumatoid arthritis; TNFR Fc fusion protein

Indexed keywords

ETANERCEPT; METHOTREXATE;

ADULT; ARTICLE; BENIGN TUMOR; BONE EROSION; BRAIN HEMORRHAGE; BREAST CARCINOMA; BREAST DISEASE; CARDIOVASCULAR DISEASE; CELLULITIS; CLINICAL ASSESSMENT TOOL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; EYE DISEASE; FEMALE; FEMUR FRACTURE; FRAGILITY FRACTURE; GASTROINTESTINAL DISEASE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HERPES ZOSTER; HUMAN; HUMERUS FRACTURE; HYPERLIPIDEMIA; HYPERURICEMIA; INFECTION; INJECTION SITE REACTION; INJURY; INTOXICATION; JOINT RADIOGRAPHY; KIDNEY DISEASE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM DISEASE; MENTAL DISEASE; METABOLIC DISORDER; MONOTHERAPY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE TOXICITY; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SKIN DISEASE; SKULL FRACTURE; THORAX DISEASE; VAN DER HEIJDE MODIFIED SHARP SCORE; VASCULAR DISEASE;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 79961102216     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110014     Document Type: Article

References (24)

1. Keystone EC. Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists - an opportunity to improve outcomes. Nat Clin Pract Rheumatol 2006;2:594-601. (Pubitemid 44650947)
2. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861-74. (Pubitemid 350180008)
3. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84. (Pubitemid 351847559)
4. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
5. van Riel PL, Taggart AJ, Sany J, Gaubitz M, Nab HW, Pedersen R, et al. Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study. Ann Rheum Dis 2006;65:1478-83.
6. Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, et al. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial. Mod Rheumatol 2010;20:531-8.
7. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93. (Pubitemid 32162981)
8. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1983;26:1346-53.
9. Miyasaka N, Takeuchi T, Eguchi K. Guidelines for the proper use of etanercept in Japan. Mod Rheumatol 2006;16:63-7.
10. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.
11. Lipsky PE, van der Heijde DM, St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602. (Pubitemid 32162982)
12. Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37. (Pubitemid 43122183)
13. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial. Lancet 2004;363:675-81. (Pubitemid 38296553)
14. Braun J, Rau R. An update on methotrexate. Curr Opin Rheumatol 2009;21:216-23.
15. Keystone EC, Genovese MC, Klareskog L, Hsia EC, Hall ST, Miranda PC, et al. Golimumab, a human antibody to tumour necrosis factor a given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis 2009;68:789-96.
16. van Riel PL, Freundlich B, MacPeek D, Pedersen R, Foehl JR, Singh A, et al. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial. Ann Rheum Dis 2008;67:1104-10.
17. Kameda H, Amano K, Sekiguchi N, Takei H, Ogawa H, Nagasawa H, et al. Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients. Mod Rheumatol 2004;14:442-6. (Pubitemid 40028667)
18. Takeuchi T, Kameda H. The Japanese experience with biologics. Nat Rev Rheumatol 2010;6:644-52.
19. Kameda H, Sekiguchi N, Nagasawa H, Amano K, Takei H, Suzuki K, et al. Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab. Mod Rheumatol 2006;16:381-8. (Pubitemid 44921587)
20. Yamanaka H, Tanaka Y, Sekiguchi N, Inoue E, Saito K, Kameda H, et al. Retrospective study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM). Mod Rheumatol 2007;17:28-32. (Pubitemid 46455693)
21. Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, et al. Retrospective study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcome (RECONFIRM-2). Mod Rheumatol 2008;18:146-52.
22. Takeuchi T, Yamanaka H, Inoue E, Nagasawa H, Nawata M, Ikari K, et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: One-year outcome of joint destruction (RECONFIRM-2J). Mod Rheumatol 2008;18:447-52.
23. Tanaka Y, Takeuchi T, Mimori T, Saito K, Nawata M, Kameda H, et al. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis 2010;69:1286-91.
24. St. Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum 2004;50:3432-43. (Pubitemid 39488667)